LeadIQ logo
Learn more at LeadIQ.com

Insights

COVID-19 Vaccine Development Exothera has secured partnerships with prestigious organizations such as the National Institutes of Health for developing intranasal COVID-19 vaccines, presenting a significant opportunity for sales growth in the vaccine manufacturing sector.

Key Personnel Appointment The recent hiring of Dr. Patrick Thiaville as Chief Technology Officer indicates a strategic move towards expanding capabilities in RNA therapies, suggesting opportunities for sales expansion in the growing market segment of nucleic acids manufacturing services.

Strategic Partnerships Collaborations with companies like Meissa Vaccines and Quantoom Biosciences showcase Exothera's commitment to innovation and technology adoption, opening doors for sales partnerships in providing customized process development and GMP manufacturing services.

Technology Expertise Exothera leverages advanced technologies such as the scale-X platform for vaccine development, positioning the company as a competitive player in the biotechnology industry and offering opportunities for sales expansion in cutting-edge manufacturing solutions.

Revenue Potential With a revenue range of $10M - $50M, Exothera demonstrates financial stability and growth potential, making it an attractive partner for companies seeking reliable and experienced CDMOs for viral vector and nucleic acids production, leading to potential sales collaborations.

Similar companies to Exothera

Exothera Tech Stack

Exothera uses 8 technology products and services including Adobe Premiere Pro, NitroPack, Shopify, and more. Explore Exothera 's tech stack below.

  • Adobe Premiere Pro
    Audio, Video, Graphics
  • NitroPack
    Caching
  • Shopify
    E-commerce
  • Google Font API
    Font Scripts
  • X-Content-Type-Options
    Miscellaneous
  • .NET
    Programming Languages
  • PHP
    Programming Languages
  • Cloudflare Bot Management
    Security

Media & News

Exothera 's Email Address Formats

Exothera uses at least 1 format(s):
Exothera Email FormatsExamplePercentage
F.Last@exothera.worldJ.Doe@exothera.world
49%
First@exothera.worldJohn@exothera.world
1%
F.Last@exothera.worldJ.Doe@exothera.world
49%
First@exothera.worldJohn@exothera.world
1%

Frequently Asked Questions

Where is Exothera 's headquarters located?

Minus sign iconPlus sign icon
Exothera 's main headquarters is located at Allée Centrale de Jumet 52 Jumet, 6040 BE. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Exothera 's official website and social media links?

Minus sign iconPlus sign icon
Exothera 's official website is exothera.world and has social profiles on LinkedIn.

How much revenue does Exothera generate?

Minus sign iconPlus sign icon
As of October 2024, Exothera 's annual revenue reached $35M.

What is Exothera 's SIC code NAICS code?

Minus sign iconPlus sign icon
Exothera 's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Exothera have currently?

Minus sign iconPlus sign icon
As of October 2024, Exothera has approximately 201 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Business Officer: D. L.Chief Technology Officer: H. P. L.Chief Operating Officer: C. B.. Explore Exothera 's employee directory with LeadIQ.

What industry does Exothera belong to?

Minus sign iconPlus sign icon
Exothera operates in the Biotechnology Research industry.

What technology does Exothera use?

Minus sign iconPlus sign icon
Exothera 's tech stack includes Adobe Premiere ProNitroPackShopifyGoogle Font APIX-Content-Type-Options.NETPHPCloudflare Bot Management.

What is Exothera 's email format?

Minus sign iconPlus sign icon
Exothera 's email format typically follows the pattern of . Find more Exothera email formats with LeadIQ.
Exothera

Exothera

Biotechnology ResearchJumet, Belgium201-500 Employees

Exothera is a contract research, development, and manufacturing organization (CDMO) dedicated to viral vector and nucleic acids production. As a technology-driven company, Exothera provides best-in-class bioprocessing expertise that capitalizes on the best and most innovative manufacturing technologies developed within the Univercells group. The company delivers accelerated discovery services as well as process development/optimization to rapidly reach GMP clinical and commercial production of viral vectors and nucleic acids. At Exothera and Univercells, Our mission is to make life-changing therapies available to all.

As a Univercells company, Exothera capitalizes on novel manufacturing technologies and best-in-class bioprocessing expertise to provide custom-made process optimization and GMP clinical and commercial production of viral vectors. Based on its extensive technology expertise, Exothera selects technologies to optimally answer customer needs for cost-effective and agile viral vector manufacturing.

Company number: 0744643660 
VAT: BE0744643660 

Section iconCompany Overview

Headquarters
Allée Centrale de Jumet 52 Jumet, 6040 BE
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
201-500

Section iconFunding & Financials

  • $10M$50M

    Exothera 's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $10M$50M

    Exothera 's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.